KLRS FY 2020 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$73,000

Operating Income

-$71M

Net Income

-$70M

EPS (Diluted)

$-59.67

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$61M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$371M

Total Liabilities

$18M

Stockholders' Equity

$353M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$165,000	-100.0%
Gross Profit	-$73,000	$0	—
Operating Income	-$71M	-$27M	-167.1%
Net Income	-$70M	-$24M	-192.7%